Advertisement
Canada markets open in 4 hours 57 minutes
  • S&P/TSX

    21,953.80
    +78.01 (+0.36%)
     
  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     
  • DOW

    39,331.85
    +162.33 (+0.41%)
     
  • CAD/USD

    0.7312
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    83.01
    +0.20 (+0.24%)
     
  • Bitcoin CAD

    83,200.55
    -2,412.90 (-2.82%)
     
  • CMC Crypto 200

    1,309.00
    -25.92 (-1.94%)
     
  • GOLD FUTURES

    2,355.30
    +21.90 (+0.94%)
     
  • RUSSELL 2000

    2,033.87
    +3.81 (+0.19%)
     
  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    20,256.25
    +1.00 (+0.00%)
     
  • VOLATILITY

    12.15
    +0.12 (+1.00%)
     
  • FTSE

    8,145.57
    +24.37 (+0.30%)
     
  • NIKKEI 225

    40,580.76
    +506.07 (+1.26%)
     
  • CAD/EUR

    0.6793
    -0.0007 (-0.10%)
     

Stocks in play: Oncolytics Biotech® Inc.

Announced that the Company received productive feedback from its Type C meeting with the U.S. Food and Drug Administration (FDA), supporting the planned potential registration-enabling trial for pelareorep in HR+/HER2- metastatic breast cancer. Oncolytics Biotech® Inc. shares T.ONC are trading down $0.03 at $1.39.

Read: